Line 794: | Line 794: | ||
<p>Pyroptosis is a form of lytic programmed cell death with inflammation. Recent studies reported that the N-terminal of GSDMD acts as an effector of pyroptosis. Full length GSDMD (GSDMD FL) is cleaved by Caspase 1, releasing the pore-forming domain (GSDMD-N275), which can oligomerize and make pores on the cell membrane. Formation of pores causes cell to swell, leading to membrane rupture and massive leakage of cytosolic contents<sup>1</sup>.</p> | <p>Pyroptosis is a form of lytic programmed cell death with inflammation. Recent studies reported that the N-terminal of GSDMD acts as an effector of pyroptosis. Full length GSDMD (GSDMD FL) is cleaved by Caspase 1, releasing the pore-forming domain (GSDMD-N275), which can oligomerize and make pores on the cell membrane. Formation of pores causes cell to swell, leading to membrane rupture and massive leakage of cytosolic contents<sup>1</sup>.</p> | ||
<div class="h2">The N-terminal of GSDMD execute the function of pyroptosis in cells</div> | <div class="h2">The N-terminal of GSDMD execute the function of pyroptosis in cells</div> | ||
− | <p>We fused eGFP with GSDMD-N275 and GSDMD FL (full length) respectively. Then the corresponding plasmids were transfected into Hela GSDMD | + | <p>We fused eGFP with GSDMD-N275 (N-terminal 275 amino acids) and GSDMD FL (full length), respectively. Then the corresponding |
+ | plasmids were transfected into Hela GSDMD knockout (KO) cell. Cell microscopy showed that the cells | ||
+ | transfected with GSDMD-N275 underwent pyroptosis while the cells with GSDMD FL did not (<b>Figure 1</b>). | ||
+ | We also tested the cell viability through an ATP assay (CellTiter-Glo<sup>®</sup> Luminescent Cell Viability | ||
+ | Assay) and demonstrated that GSDMD-N275 and mutants of GSDMD FL have different abilities to induce | ||
+ | pyroptosis (<b>Figure 2</b>).</p> | ||
<div style="width: 100%; margin: 30px auto"> | <div style="width: 100%; margin: 30px auto"> | ||
<img src="https://static.igem.org/mediawiki/2018/d/d7/T--HZAU-China--basicPart1.png.png" width="100%" alt=""> | <img src="https://static.igem.org/mediawiki/2018/d/d7/T--HZAU-China--basicPart1.png.png" width="100%" alt=""> | ||
</div> | </div> | ||
− | <p><b>Figure 1.</b> Microscopy of the Hela GSDMD KO cells transfected with pCS2-eGFP-GSDMD FL and pCS2-eGFP-GSDMD-N275, respectively. Pyroptotic cells are pointed by red arrow.</p> | + | <p><b>Figure 1.</b> Microscopy of the Hela GSDMD KO cells transfected with pCS2-eGFP-GSDMD FL (above) and |
+ | pCS2-eGFP-GSDMD-N275 (below), respectively. Pyroptotic cells are pointed by red arrow.</p> | ||
<div class="collapseDiv"> | <div class="collapseDiv"> | ||
<label for="zhedie-toggle1">Method</label> | <label for="zhedie-toggle1">Method</label> | ||
Line 804: | Line 810: | ||
<div id="zhedie1" class="text-success text-left"> | <div id="zhedie1" class="text-success text-left"> | ||
<b>Preparation of Cells for transfection</b><br> | <b>Preparation of Cells for transfection</b><br> | ||
− | 1. Grow Hela GSDMD KO cells in a humidified | + | 1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO<sub>2</sub> tissue-culture incubator.<br> |
− | + | 2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow.<br> | |
− | 2. Count the cells using a hemocytometer. Seed in 24-well ( | + | <b>Transfection</b> <br> |
− | <b>Transfection</b><br> | + | |
1. Dilute 0.5 μg DNA into 50 μl jetPRIME<sup>®</sup> buffer (supplied). Mix by vortexing.<br> | 1. Dilute 0.5 μg DNA into 50 μl jetPRIME<sup>®</sup> buffer (supplied). Mix by vortexing.<br> | ||
2. Add 1 μl jetPRIME<sup>®</sup>, vortex for 10 s, spin down briefly.<br> | 2. Add 1 μl jetPRIME<sup>®</sup>, vortex for 10 s, spin down briefly.<br> | ||
3. Incubate for 10 min at RT.<br> | 3. Incubate for 10 min at RT.<br> | ||
− | 4. Add 50μl of transfection mix per well drop wise onto the cells in serum containing | + | 4. Add 50μl of transfection mix per well drop wise onto the cells in serum containing medium, |
− | + | and distribute evenly.<br> | |
5. Gently rock the plates back and forth and from side to side.<br> | 5. Gently rock the plates back and forth and from side to side.<br> | ||
− | 6. If needed, replace transfection medium after 4 h by cell growth medium and return the | + | 6. If needed, replace transfection medium after 4 h by cell growth medium and return the plates |
− | + | to the incubator.<br> | |
− | Observation is taken after 1.5 h<br><br> | + | Observation is taken after 1.5 h.<br><br> |
</div> | </div> | ||
</div> | </div> | ||
Line 822: | Line 827: | ||
<img src="https://static.igem.org/mediawiki/2018/f/f5/T--HZAU-China--basicPart2.png" width="100%" alt=""> | <img src="https://static.igem.org/mediawiki/2018/f/f5/T--HZAU-China--basicPart2.png" width="100%" alt=""> | ||
</div> | </div> | ||
− | <p><b>Figure 2.</b> Cell viability of the 293T cells transfected with pCS2-Flag-GSDMD FL, pCS2-Flag-GSDMD-N275, pCS2-Flag-GSDMD L290D, pCS2-Flag-GSDMD Y373D | + | <p><b>Figure 2.</b> Cell viability of the 293T cells transfected with pCS2-Flag-GSDMD FL, |
+ | pCS2-Flag-GSDMD-N275, pCS2-Flag-GSDMD L290D, pCS2-Flag-GSDMD Y373D, pCS2-Flag-GSDMD A377D, | ||
+ | respectively. Asterisks indicate the statistically significant differences. ATP-based cell | ||
+ | viability was measured (n=6).</p> | ||
<div class="collapseDiv"> | <div class="collapseDiv"> | ||
<label for="zhedie-toggle2">Method</label> | <label for="zhedie-toggle2">Method</label> | ||
<input type="checkbox" id="zhedie-toggle2"> | <input type="checkbox" id="zhedie-toggle2"> | ||
<div id="zhedie2" class="text-success text-left"> | <div id="zhedie2" class="text-success text-left"> | ||
− | <b>Preparation of Cells for | + | <b>Preparation of Cells for ATP assay</b><br> |
− | 1. Grow | + | 1. Grow HEK293T cells in a humidified 37 °C, 5% CO<sub>2</sub> tissue-culture incubator.<br> |
− | + | 2. Count the cells using a hemocytometer. Seed in 96-well (1 × 10^4 per well) and grow | |
− | 2. Count the cells using a hemocytometer. Seed in | + | |
overnight.<br> | overnight.<br> | ||
− | + | 3. Transfect 0.5 μg DNA per well.<br> | |
− | + | 4. Equilibrate the plate and its contents at room temperature for approximately 30 minutes | |
− | + | after 20 h.<br> | |
− | + | 5. Add a volume of CellTiter-Glo<sup>®</sup> Reagent equal to the volume of cell culture medium present in | |
− | + | each well. (add 100 μl of reagent to 100 μl of medium containing cells for a 96-well plate).<br> | |
− | + | 6. Mix contents for 2 minutes on an orbital shaker to induce cell lysis.<br> | |
− | + | 7. Allow the plate to incubate at room temperature for 10 minutes to stabilize luminescent | |
− | + | signal.<br> | |
− | + | 8. Record luminescence.<br><br> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class="h2"> | + | <div class="h2">GSDMD-N275 can lyse bacteria</div> |
− | <p>Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) in <i>Salmonella enterica</i> serovar Typhimurium str. SL1344 <i> | + | <p>Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) in <i>Salmonella enterica</i> |
− | + | serovar Typhimurium str. SL1344 Δ<i>sifA</i> is under the control of P<sub>tet</sub>. The | |
− | + | colony-forming unit (CFU) | |
+ | was measured for counting the number of viable bacterial cells (<b>Figure 3</b>). This result shows that | ||
+ | eGFP-GSDMD-N275 exhibits cytotoxicity in bacteria.</p> | ||
<div style="width: 30%; margin: 30px auto"> | <div style="width: 30%; margin: 30px auto"> | ||
<img src="https://static.igem.org/mediawiki/2018/f/fb/T--HZAU-China--basicPart3.jpg" width="100%" alt=""> | <img src="https://static.igem.org/mediawiki/2018/f/fb/T--HZAU-China--basicPart3.jpg" width="100%" alt=""> | ||
</div> | </div> | ||
− | <p><b>Figure 3.</b> CFU comparison between the SL1344 <i> | + | <p><b>Figure 3.</b> CFU comparison between the SL1344 Δ<i>sifA</i> cells with eGFP-GSDMD-N275 plasmid |
− | + | and with the | |
− | + | empty vector. In each group, ATc (15μg/ml) was added into medium when bacterium grew to logarithmic | |
− | + | phase (OD = 0.6~0.8). Vector refers to bacterium containing a high copy number plasmid which only | |
+ | expresses TetR under the control of P<sub>tet</sub>. CFU for vector | ||
+ | and eGFP-GSDMD-N275 are shown in the logarithmic form (log10) (n=3). </p> | ||
<div class="collapseDiv"> | <div class="collapseDiv"> | ||
<label for="zhedie-toggle3">Method</label> | <label for="zhedie-toggle3">Method</label> | ||
<input type="checkbox" id="zhedie-toggle3"> | <input type="checkbox" id="zhedie-toggle3"> | ||
<div id="zhedie3" class="text-success text-left"> | <div id="zhedie3" class="text-success text-left"> | ||
− | + | 1. Bacteria are cultured overnight in LB broth containing corresponding antibiotics, and | |
dilute each 1 volume overnight cultures with 100 volume fresh LB containing antibiotics. | dilute each 1 volume overnight cultures with 100 volume fresh LB containing antibiotics. | ||
Culture in 37℃ 200 rpm.<br> | Culture in 37℃ 200 rpm.<br> | ||
2. When OD reaching to 0.6-0.8, add anhydrotetracycline with final concentration of | 2. When OD reaching to 0.6-0.8, add anhydrotetracycline with final concentration of | ||
− | + | μg/ml to induce the expression of EGFP-GSDMD-N275.<br> | |
− | 3. Take 100 μl diluted culture to plate on LB agar plates containing appropriate | + | 3. Take 100 μl diluted culture to plate on LB agar plates containing appropriate concentration |
− | + | of antibody after 1.5 hours of induce.<br> | |
Observation is taken overnight.<br><br> | Observation is taken overnight.<br><br> | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class="h2"> | + | <div class="h2">GSDMD-N275 from lytic bacteria induces host cell pyroptosis</div> |
− | <p>Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) is under the control of tet promoter in <i> | + | <p>Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) is under the control of tet |
− | + | promoter in Δ<i>sifA</i> SL1344. Hela GSDMD KO cells were infected with Δ<i>sifA</i> SL1344. | |
− | + | Inducer ATc | |
− | + | (16μg/mL) were added 3h after infection. Microscopy shows that eGFP-GSDMD-N275 located in cytoplasm | |
− | + | after 5 min of induction and triggered pyroptosis after 30 min of induction (<b>Figure 4</b>). After | |
− | + | 1.5 h | |
− | + | of induction, Hela GSDMD KO cells underwent second necrosis caused by bacterial infection without | |
− | + | inducer. Morphology of this process is similar to pyroptosis<sup>4</sup>. Thus, the population of | |
+ | ruptured | ||
+ | cells was counted. There is 1.96 fold change between control group and induced group (<b>Figure 5</b>). | ||
+ | So | ||
+ | the pyroptosis of host cell in the induced group was triggered by eGFP-GSDMD-N275 not by bacterial | ||
+ | infection. | ||
</p> | </p> | ||
<div style="width: 90%; margin: 0 auto"> | <div style="width: 90%; margin: 0 auto"> | ||
<img src="https://static.igem.org/mediawiki/2018/b/b3/T--HZAU-China--basicPart4.png" width="100%" alt=""> | <img src="https://static.igem.org/mediawiki/2018/b/b3/T--HZAU-China--basicPart4.png" width="100%" alt=""> | ||
</div> | </div> | ||
− | <p><b>Figure 4.</b> Hela GSDMD KO cells were infected with <i> | + | <p><b>Figure 4.</b> Hela GSDMD KO cells were infected with Δ<i>sifA</i> SL1344 containing high copy |
− | + | number plasmids | |
+ | which express eGFP-GSDMD-N275 under the control of ATc. Photographs were captured 5 min, 30 min, 90 min | ||
+ | after induction, respectively. </p> | ||
<div style="width: 50%; margin: 0 auto"> | <div style="width: 50%; margin: 0 auto"> | ||
<img src="https://static.igem.org/mediawiki/2018/2/22/T--HZAU-China--basicPart5.png" width="100%" alt=""> | <img src="https://static.igem.org/mediawiki/2018/2/22/T--HZAU-China--basicPart5.png" width="100%" alt=""> | ||
</div> | </div> | ||
− | <p><b>Figure 5.</b> | + | <p><b>Figure 5.</b>Ruptured cells in a |
+ | field of | ||
+ | view were counted. </p> | ||
<div class="collapseDiv"> | <div class="collapseDiv"> | ||
<label for="zhedie-toggle4">Method</label> | <label for="zhedie-toggle4">Method</label> | ||
Line 901: | Line 913: | ||
<div id="zhedie4" class="text-success text-left"> | <div id="zhedie4" class="text-success text-left"> | ||
<b>Preparation of Cells for Infection</b><br> | <b>Preparation of Cells for Infection</b><br> | ||
− | 1. Grow Hela GSDMD KO cells in a humidified | + | 1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO<sub>2</sub> tissue-culture incubator.<br> |
− | + | 2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow | |
− | 2. Count the cells using a hemocytometer. Seed in 24-well ( | + | |
overnight.<br> | overnight.<br> | ||
− | <b>Preparation of Bacteria</b><br> | + | <b>Preparation of Bacteria</b> <br> |
− | 1. Grow bacteria overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at | + | 1. Grow bacteria overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking |
incubator (200 rpm).<br> | incubator (200 rpm).<br> | ||
2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB in a | 2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB in a | ||
− | loosely capped 50-mL tube. Incubate at | + | loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log |
phase.<br> | phase.<br> | ||
− | 3. Pellet 1 mL of the <i>Salmonella</i> subculture by centrifugation at 1,000×g in a microfuge | + | 3. Pellet 1 mL of the <i>Salmonella</i> subculture by centrifugation at 1,000×g in a microfuge |
− | 2 min at room temperature.<br> | + | for 2 |
+ | min at room temperature.<br> | ||
4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.<br> | 4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.<br> | ||
<b>Infection</b><br> | <b>Infection</b><br> | ||
1. Aspirate media and rinse the monolayer twice with PBS.<br> | 1. Aspirate media and rinse the monolayer twice with PBS.<br> | ||
− | 2. Inoculate cells with bacteria (MOI = 100) by adding bacteria directly to the | + | 2. Inoculate cells with bacteria (MOI = 100) by adding bacteria directly to the cell-culture |
− | + | supernatant.<br> | |
− | 3. Incubate for 2 h at | + | 3. Incubate for 2 h at 37 °C in 5% CO<sub>2</sub>.<br> |
4. Aspirate media and wash.<br> | 4. Aspirate media and wash.<br> | ||
− | 5. Add fresh GM containing 100 μg/mL gentamicin and 16 μg/mL | + | 5. Add fresh GM containing 100 μg/mL gentamicin and 16 μg/mL incubate at 37 °C in 5% CO<sub>2</sub>.<br> |
− | Observation is taken after 5 min, 30 min, | + | Observation is taken after 5 min, 30 min, 90min.<br><br> |
</div> | </div> |
Revision as of 02:03, 18 October 2018
Pyroptosis is a form of lytic programmed cell death with inflammation. Recent studies reported that the N-terminal of GSDMD acts as an effector of pyroptosis. Full length GSDMD (GSDMD FL) is cleaved by Caspase 1, releasing the pore-forming domain (GSDMD-N275), which can oligomerize and make pores on the cell membrane. Formation of pores causes cell to swell, leading to membrane rupture and massive leakage of cytosolic contents1.
We fused eGFP with GSDMD-N275 (N-terminal 275 amino acids) and GSDMD FL (full length), respectively. Then the corresponding plasmids were transfected into Hela GSDMD knockout (KO) cell. Cell microscopy showed that the cells transfected with GSDMD-N275 underwent pyroptosis while the cells with GSDMD FL did not (Figure 1). We also tested the cell viability through an ATP assay (CellTiter-Glo® Luminescent Cell Viability Assay) and demonstrated that GSDMD-N275 and mutants of GSDMD FL have different abilities to induce pyroptosis (Figure 2).
Figure 1. Microscopy of the Hela GSDMD KO cells transfected with pCS2-eGFP-GSDMD FL (above) and pCS2-eGFP-GSDMD-N275 (below), respectively. Pyroptotic cells are pointed by red arrow.
1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow.
Transfection
1. Dilute 0.5 μg DNA into 50 μl jetPRIME® buffer (supplied). Mix by vortexing.
2. Add 1 μl jetPRIME®, vortex for 10 s, spin down briefly.
3. Incubate for 10 min at RT.
4. Add 50μl of transfection mix per well drop wise onto the cells in serum containing medium, and distribute evenly.
5. Gently rock the plates back and forth and from side to side.
6. If needed, replace transfection medium after 4 h by cell growth medium and return the plates to the incubator.
Observation is taken after 1.5 h.
Figure 2. Cell viability of the 293T cells transfected with pCS2-Flag-GSDMD FL, pCS2-Flag-GSDMD-N275, pCS2-Flag-GSDMD L290D, pCS2-Flag-GSDMD Y373D, pCS2-Flag-GSDMD A377D, respectively. Asterisks indicate the statistically significant differences. ATP-based cell viability was measured (n=6).
1. Grow HEK293T cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 96-well (1 × 10^4 per well) and grow overnight.
3. Transfect 0.5 μg DNA per well.
4. Equilibrate the plate and its contents at room temperature for approximately 30 minutes after 20 h.
5. Add a volume of CellTiter-Glo® Reagent equal to the volume of cell culture medium present in each well. (add 100 μl of reagent to 100 μl of medium containing cells for a 96-well plate).
6. Mix contents for 2 minutes on an orbital shaker to induce cell lysis.
7. Allow the plate to incubate at room temperature for 10 minutes to stabilize luminescent signal.
8. Record luminescence.
Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) in Salmonella enterica serovar Typhimurium str. SL1344 ΔsifA is under the control of Ptet. The colony-forming unit (CFU) was measured for counting the number of viable bacterial cells (Figure 3). This result shows that eGFP-GSDMD-N275 exhibits cytotoxicity in bacteria.
Figure 3. CFU comparison between the SL1344 ΔsifA cells with eGFP-GSDMD-N275 plasmid and with the empty vector. In each group, ATc (15μg/ml) was added into medium when bacterium grew to logarithmic phase (OD = 0.6~0.8). Vector refers to bacterium containing a high copy number plasmid which only expresses TetR under the control of Ptet. CFU for vector and eGFP-GSDMD-N275 are shown in the logarithmic form (log10) (n=3).
2. When OD reaching to 0.6-0.8, add anhydrotetracycline with final concentration of μg/ml to induce the expression of EGFP-GSDMD-N275.
3. Take 100 μl diluted culture to plate on LB agar plates containing appropriate concentration of antibody after 1.5 hours of induce.
Observation is taken overnight.
Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) is under the control of tet promoter in ΔsifA SL1344. Hela GSDMD KO cells were infected with ΔsifA SL1344. Inducer ATc (16μg/mL) were added 3h after infection. Microscopy shows that eGFP-GSDMD-N275 located in cytoplasm after 5 min of induction and triggered pyroptosis after 30 min of induction (Figure 4). After 1.5 h of induction, Hela GSDMD KO cells underwent second necrosis caused by bacterial infection without inducer. Morphology of this process is similar to pyroptosis4. Thus, the population of ruptured cells was counted. There is 1.96 fold change between control group and induced group (Figure 5). So the pyroptosis of host cell in the induced group was triggered by eGFP-GSDMD-N275 not by bacterial infection.
Figure 4. Hela GSDMD KO cells were infected with ΔsifA SL1344 containing high copy number plasmids which express eGFP-GSDMD-N275 under the control of ATc. Photographs were captured 5 min, 30 min, 90 min after induction, respectively.
Figure 5.Ruptured cells in a field of view were counted.
1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow overnight.
Preparation of Bacteria
1. Grow bacteria overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm).
2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log phase.
3. Pellet 1 mL of the Salmonella subculture by centrifugation at 1,000×g in a microfuge for 2 min at room temperature.
4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.
Infection
1. Aspirate media and rinse the monolayer twice with PBS.
2. Inoculate cells with bacteria (MOI = 100) by adding bacteria directly to the cell-culture supernatant.
3. Incubate for 2 h at 37 °C in 5% CO2.
4. Aspirate media and wash.
5. Add fresh GM containing 100 μg/mL gentamicin and 16 μg/mL incubate at 37 °C in 5% CO2.
Observation is taken after 5 min, 30 min, 90min.
Name | Type | Description | Designer | Length(bp) |
---|---|---|---|---|
BBa_K2632002 | Promoter | Promoter sifA | Mo Qiqin | 331 |
BBa_K2632003 | Coding | N-terminal of GasderminD (1-275aa) | Zhujun Xia | 825 |
BBa_K2632004 | Coding | Full length Gasdermin D | Zhujun Xia | 1455 |
BBa_K2632005 | Coding | L290D mutant of full length Gasdermin D | Zhujun Xia | 1455 |
BBa_K2632007 | Coding | A377D mutant of full length Gasdermin D. | Zhujun Xia | 1455 |
1 Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111-116, doi:10.1038/nature18590 (2016).
2 He, W. T. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell research 25, 1285-1298, doi:10.1038/cr.2015.139 (2015).